The weight loss drug Zepbound (tirzepatide) led to 50 percent more weight loss in a 72-week trial than Wegovy (semaglutide). Participants taking Zepbound lost 50 pounds (lb) on average ...

Weight-loss medications known as glucagon-like peptide-1 (GLP-1) agonists, which have gained popularity for treating type 2 diabetes and obesity, have been shown to have the surprising secondary ...

Weight loss drugs are popular for helping patients quickly shed pounds Drugs like Ozempic are controversial for their side effects Side effects of some drugs can range from nausea to kidney ...

Novo Nordisk CEO Lars Fruergaard Jorgensen is stepping down as competition in the weight-loss drug space pressured the company's stock. "Considering the recent market challenges, the share price ...

Gina admitted her and Travis still “kind of disagree” about some things regarding the move. GettyImages-1390926911 Gina Kirschenheiter ... being mocked for his weight and his name by Gina.

I have finally found some success with the new GLP-1 weight loss drugs. Will it stick? Who knows. But I have lost 20 pounds so far and am feeling better than I have in a decade. And I am hopeful ...

That’s why the results of recent clinical trials were surprising — and welcome — for some: In study after study, injected GLP-1 weight loss medications appear to work better on average for ...

Share on Pinterest A Wegovy weight loss pill from Novo Nordisk is forthcoming, providing an alternative to injectable GLP-1 drugs. Mads Claus Rasmussen/Ritzau Scanpix/AFP via Getty Images Federal ...

Share on Pinterest Time-restricted eating may help sustain weight loss results in the long term, a new trial suggests. Peter Dazeley/Getty Images Over the last few years, the dietary pattern of ...

Jason Kelce is opening up about the weight loss journey he's been on since retiring from the NFL in March 2024. The former Philadelphia Eagles center, 37, told brother Travis Kelce, 35 ...